Key things are:
*It reduces tumor size,
*More tumors become operable,
*it extends the life of those treated with it:
*Surgical resection in LAPC is critical, improving the 5-year survival rate from ~5% to >20%...
*Patients undergoing surgical resection had significantly better survival than patients who did not:
median Overall Survival: 35.3 vs. 16.3 months and 3-year survival rate: 50.0% vs. 11.0% (p<0.001).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.010(0.93%) |
Mkt cap ! $20.14M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.08 | $1.06 | $16.77K | 15.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6725 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 11531 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |